http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106769325-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19aa45cdd293d8181a66250807cc69bf
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N1-28
filingDate 2017-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3b478864254d6b733439fdcfdbb553b
publicationDate 2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106769325-A
titleOfInvention A kind of blood nanometer coagulant
abstract The invention belongs to the technical field of blood nanometer coagulant, disclose a kind of blood nanometer coagulant, it is characterized in that, it is made up of the polymer of α hydrogen ω hydroxyls (the second diyl of oxygen 1,2), polyvinylpyrrolidone, polysorbate, polysorbate, SiO 2 powder and isopropanol;The volume ratio of the polymer of the α hydrogen ω hydroxyls (the second diyl of oxygen 1,2), polysorbate, polysorbate and isopropanol is 1~5:60~80:25~45:1000;The mass volume ratio of the polyvinylpyrrolidone and isopropanol is 3~6g:1000ml;The mass volume ratio of the SiO 2 powder and the isopropanol is 8 16g:1000ml.Coagulant obtained by the present invention can effectively shorten the time of blood clotting, blood wall built-up phenomenon will not be formed, separate serum effect fine, without interference with the result of biochemical and immunological experiment detection, the term of validity is long, possesses excellent performance, and blood coagulation accelerator of the present invention is aseptic aqua type, transportation safety, it is aseptic, without thermal source, can stabilizing blood sugar result.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112546677-A
priorityDate 2017-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09638
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415968269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958

Total number of triples: 26.